Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 42

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 42
---
) of the Exchange Act, before making a decision about investing in our securities. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. If any risks actually occur, our business, financial condition and results of operations may be materially and adversely affected. In such an event, the trading price of our common stock could decline and you could lose part or all of your investment.

For more information about our SEC filings, please
see “Where You Can Find More Information” and “Incorporation by Reference.”

Additional risks not presently known or that we
presently consider to be immaterial could subsequently materially and adversely affect our financial condition, results of operations,
business, and prospects.

<div align='center'>10

USE OF PROCEEDS</div>

We intend to use the net proceeds from the sale
of the securities from offerings under this prospectus for capital expenditures, repayment and refinancing of debt, research and development
expenditures, acquisitions of additional companies or technologies, investments and general corporate purposes, including working capital
unless the applicable prospectus supplement states otherwise. General corporate purposes may include working capital purposes.

We may temporarily invest the net proceeds in
investment-grade, interest-bearing securities until they are used for their stated purpose. We have not determined the amount of net proceeds
to be used specifically for such purposes. As a result, we will retain broad discretion over the allocation of net proceeds. We would
not receive proceeds from sales by our security holders.

<div align='center'>11

SELLING STOCKHOLDERS</div>

Selling stockholders are persons or entities that,
directly or indirectly, have acquired or will from time to time acquire from us, our securities in various private transactions. Such
selling stockholders may be parties to registration rights agreements with us, or we otherwise may have agreed or will agree to register
their securities for sale. Certain holders of our securities, as well as their transferees, pledgees, donees, or successors, all of whom
we refer to as “Selling Stockholders,” may from time to time offer and sell the securities pursuant to this prospectus
and any applicable prospectus supplement.

The applicable prospectus supplement will set
forth the name of each selling security holder and the number of and type of securities beneficially owned by such selling security holder
that are covered by such prospectus supplement. The applicable prospectus supplement